100 Active Studies

Vaccine Clinical Trials Near You

Find 100 actively recruiting vaccine research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

100Active Trials
214+Locations
296,649Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Vaccine Clinical Trials

Vaccine clinical trials are recruiting across 214 cities. Here are the cities with the most active studies:

Vaccine Trial Phases

PHASE2(33 studies)
PHASE1(22 studies)
PHASE3(18 studies)
NA(17 studies)
PHASE4(10 studies)
EARLY_PHASE1(1 study)

59 research organizations are sponsoring vaccine trials.

About Vaccine

Vaccines are biological preparations that provide active immunity against specific infectious diseases. Clinical trials for vaccines test safety, immunogenicity, and efficacy in preventing disease. Current research includes vaccines for cancer, HIV, malaria, and improved formulations for existing diseases.

Clinical trials are advancing new treatments for vaccine. Currently, 100 studies are recruiting a combined 296,649 participants across the United States. Research is being conducted by 59 organizations including University of California, Los Angeles, Yale University, Pfizer and 56 others.

2026 Vaccine Research Landscape

As of July 2026, the vaccine clinical trial landscape includes 100 actively recruiting studies across 214 cities in the United States. These studies are collectively seeking 296,649 participants, with an average enrollment target of 2,966 per study.

The research spans multiple phases of development: 33 studies are in PHASE2, 22 studies are in PHASE1, 18 studies are in PHASE3, 17 studies are in NA, 10 studies are in PHASE4, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some vaccine treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 59 different organizations, including University of California, Los Angeles, Yale University, Pfizer, Masaryk University, Brooklyn Clinical Research, and 54 others. The large number of sponsors reflects significant research interest and investment in vaccine treatment advancement.

Geographically, vaccine trials are most concentrated in New York, New York (11 trials); Los Angeles, California (10 trials); Atlanta, Georgia (9 trials); Miami, Florida (9 trials); Houston, Texas (8 trials) and 7 other cities.

Featured Vaccine Studies

Highlighted recruiting studies for vaccine, selected by enrollment size and research scope.

RecruitingNCT06831383 · NA

The STOP-HPV Scale Up Study

Human papillomavirus (HPV) causes 35,900 US cancer cases per year, 4,000 deaths, and $4 billion in can In this study, the investigators will conduct a 3-arm clustered randomized controlled trial (RCT) in an estimated 72 practices from up to 8 health systems to evaluate the effectiveness and cost effectiveness of two potentially scalable implementation strategies (based on prior work) to increase t...

Sponsor: University of California, Los Angeles· 100,000 participants· 1 location (Alexandria)
View full study details →
RecruitingNCT05796505 · NA

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness of these interventions through rapid cycle, cluster randomized trials in the Pennsylvania prison sy...

Sponsor: Yale University· 37,122 participants· 1 location (Schwenksville)
View full study details →
RecruitingNCT07282665 · PHASE3

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adults 65 years of age or older. The participants will receive either the C. difficile vaccine or placebo (saline). A placebo does not contain any active ingredients. The vaccines will be given as a shot ...

Sponsor: Pfizer· 32,000 participants· 10 locations (Athens, Guntersville, Huntsville, Sun City)
View full study details →

Frequently Asked Questions About Vaccine Clinical Trials

Are there vaccine clinical trials near me?

Yes, there are 100 vaccine clinical trials currently recruiting across 214+ cities in the United States, including New York, New York; Los Angeles, California; Atlanta, Georgia. Browse the studies above to find one at a location convenient for you.

How do I join a vaccine clinical trial?

To join a vaccine clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are vaccine clinical trials free?

Yes, participation in vaccine clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of vaccine treatments are being studied?

Current vaccine clinical trials are testing a range of approaches across PHASE2 (33 studies), PHASE1 (22 studies), PHASE3 (18 studies), NA (17 studies), PHASE4 (10 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 59 research organizations.

Is it safe to participate in vaccine clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated July 16, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov